Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer

Sponsor
University of Wisconsin, Madison (Other)
Overall Status
Completed
CT.gov ID
NCT02096783
Collaborator
National Cancer Institute (NCI) (NIH)
15
1
4
21
0.7

Study Details

Study Description

Brief Summary

This randomized pilot clinical trial studies the feasibility of a pre-operative and/or post-operative scripted sexual health informational intervention and how well it works in improving sexual function in patients with gynecologic cancer. Discussing sexual outcomes and counseling options with patients may help improve sexual outcomes and/or anxiety after primary gynecologic cancer treatment.

Condition or Disease Intervention/Treatment Phase
  • Other: informational intervention
  • Other: counseling intervention
  • Other: questionnaire administration
N/A

Detailed Description

PRIMARY OBJECTIVES:
  1. To evaluate the feasibility of patient recruitment, including time required to consent, enroll and retain the necessary number of participants.

  2. To determine the distribution of candidate primary patient-reported outcome measures, including time to resumption of sexual activity, global satisfaction with sex life, sexual function and anxiety in this particular population.

  3. To establish the prevalence of patient recall of the intervention to determine the most effective time at which to deliver the intervention.

OUTLINE: Patients are randomized to 1 of 4 treatment arms.

ARM I: Patients receive standard counseling at both the pre-operative and 2-4 week post-operative visit.

ARM II: Patients receive standard counseling at the pre-operative visit and the scripted sexual health intervention at the 2-4 week post-operative visit.

ARM III: Patients receive standard counseling and the scripted sexual health intervention at the pre-operative visit and standard counseling at the 2-4 week post-operative visit.

ARM IV: Patients receive standard counseling and the scripted sexual health intervention at both the pre-operative and 2-4 week post-operative visit.

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Supportive Care
Official Title:
Randomized-Controlled, Pilot Study of the Effects of a Brief, Scripted Sexual Health Intervention on Sexual Function for Women With Gynecologic Cancer
Study Start Date :
Sep 1, 2014
Actual Primary Completion Date :
Jun 1, 2015
Actual Study Completion Date :
Jun 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Arm I (standard counseling)

Patients receive standard counseling at both the pre-operative and 2-4 week post-operative visit.

Other: counseling intervention
Given standard counseling
Other Names:
  • counseling and communications studies
  • Other: questionnaire administration
    Ancillary studies

    Experimental: Arm II (standard counseling, scripted intervention)

    Patients receive standard counseling at the pre-operative visit and the scripted sexual health intervention at the 2-4 week post-operative visit.

    Other: informational intervention
    Given scripted intervention

    Other: counseling intervention
    Given standard counseling
    Other Names:
  • counseling and communications studies
  • Other: questionnaire administration
    Ancillary studies

    Experimental: Arm III (standard counseling, scripted intervention)

    Patients receive standard counseling and the scripted sexual health intervention at the pre-operative visit and standard counseling at the 2-4 week post-operative visit.

    Other: informational intervention
    Given scripted intervention

    Other: counseling intervention
    Given standard counseling
    Other Names:
  • counseling and communications studies
  • Other: questionnaire administration
    Ancillary studies

    Experimental: Arm IV (standard counseling, scripted intervention)

    Patients receive standard counseling and the scripted sexual health intervention at both the pre-operative and 2-4 week post-operative visit.

    Other: informational intervention
    Given scripted intervention

    Other: counseling intervention
    Given standard counseling
    Other Names:
  • counseling and communications studies
  • Other: questionnaire administration
    Ancillary studies

    Outcome Measures

    Primary Outcome Measures

    1. Feasibility of patient recruitment [Up to 9 months]

      To inform possible issues in recruitment for a large-scale randomized controlled trial, the ratio of enrolled subjects to total eligible potential subjects as well as the time necessary to recruit those subjects will be tracked.

    Secondary Outcome Measures

    1. Resumption of sexual activity after cancer surgery [Up to 9 months]

      Resumption of sexual activity after cancer surgery will be measured using items adapted from a previous national, multi-site study of sexual outcomes following an acute myocardial infarction.

    2. Retention [Up to 9 months]

      The percentage of subjects completing the final assessment from the total number of subjects enrolled will be calculated.

    3. Satisfaction with sex life independent of specific sexual function measured by Patient Reported Outcomes Measurement Information System (PROMIS) Global Satisfaction with Sex Life questionnaire [Up to 9 months]

      Descriptive statistics will be used to summarize survey responses overall and separately for both the experimental and control arms.

    4. PROMIS Sexual Function Profile [Up to 9 months]

      Descriptive statistics will be used to summarize survey responses overall and separately for both the experimental and control arms.

    5. Recall of intervention [Up to 9 months]

      Subjects will be queried to learn whether they recall receiving physician counseling about sexual health outcomes after surgery with follow up questions regarding whether or not the patient has spoken with other healthcare providers about sexual concerns.

    6. Patient-reported anxiety measured by PROMIS Anxiety 4a short form [Up to 6 months]

      Descriptive statistics will be used to summarize survey responses overall and separately for both the experimental and control arms.

    7. Rate of referral acceptance [Up to 9 months]

      The rate of acceptance of sexual health clinic referrals as well as rates of utilization of these referrals will be tracked using medical record abstraction.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients with a new suspected or confirmed gynecologic malignancies

    • Patients plan to have primary surgery at either the University of Chicago Hospital or the University of Wisconsin Hospital

    • Patients must be English speaking

    Exclusion Criteria:
    • Previous treatment of any cancer excluding skin cancer

    • Patients with a suspected benign gynecologic process

    • Patients who are prisoners or incarcerated

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Wisconsin, Madison Madison Wisconsin United States 53792

    Sponsors and Collaborators

    • University of Wisconsin, Madison
    • National Cancer Institute (NCI)

    Investigators

    • Principal Investigator: David Kushner, University of Wisconsin, Madison

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    University of Wisconsin, Madison
    ClinicalTrials.gov Identifier:
    NCT02096783
    Other Study ID Numbers:
    • UW13080
    • NCI-2014-00471
    • UW13080
    • P30CA014520
    • 2014-0122
    • A532820
    • SMPH/OBSTET & GYNECOL/OBSTET
    First Posted:
    Mar 26, 2014
    Last Update Posted:
    Nov 18, 2019
    Last Verified:
    Nov 1, 2016

    Study Results

    No Results Posted as of Nov 18, 2019